Santhera Pharmaceuticals Holding (SANN) Price & Analysis

Compare

0 Followers

SANN Stock Chart & Stats

Day’s Range― - ―

52-Week RangeCHF7.21 - CHF17.76

Previous CloseN/A

Volume24.19K

Average Volume (3M)27.44K

Market Cap

CHF118.01M

Enterprise ValueCHF127.16M

Total Cash (Recent Filing)CHF40.92M

Total Debt (Recent Filing)CHF40.62M

Price to Earnings (P/E)2.6

Beta0.29

Next Earnings

Sep 10, 2025

EPS Estimate

-0.6

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.74

Shares Outstanding13,524,123

10 Day Avg. Volume21,893

30 Day Avg. Volume27,442

Financial Highlights & Ratios

PEG Ratio0.04

Price to Book (P/B)-1.92

Price to Sales (P/S)0.00

P/FCF Ratio-2.49

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

CHF29.98

Price Target Upside145.78% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Santhera Pharmaceuticals Holding News

PremiumThe Fly

Santhera price target raised to CHF 30 from CHF 25 at H.C. Wainwright

21d ago

PremiumRatings

Santhera Pharmaceuticals: Buy Rating Affirmed on Strong Commercial Traction and Promising Financial Outlook

21d ago

PremiumCompany Announcements

Santhera Pharmaceuticals: Transformative Year with AGAMREE Success

1M ago

PremiumRatings

Santhera Pharmaceuticals: Buy Rating Affirmed on Strategic Milestones and Growth Prospects

4M ago

PremiumThe Fly

Santhera price target lowered to CHF 25 from CHF 30 at H.C. Wainwright

9M ago

PremiumThe Fly

Santhera price target raised to CHF 28 from CHF 24 at H.C. Wainwright

2y ago

See All CH:SANN News

See All News >

Bulls Say, Bears Say

Bulls Say

European Market ExpansionThe European rollout of AGAMREE is accelerating, leading to an increase in the price target for Santhera Pharmaceuticals.

Financial StabilitySanthera's balance sheet appears healthy with potential runway through to cash flow breakeven, supported by expected top-line revenue growth.

Leadership TransitionThe appointment of Catherine Isted as Chief Financial Officer is seen as a positive transition, with the previous CFO remaining available to support the transition.

Regulatory ApprovalsAGAMREE has received acceptance by Health Canada for the New Drug Submission with Priority Review, paving the way for it to become the first DMD drug approved in Canada.

Bears Say

Market ExpectationsThe €52K reimbursement level in Germany exceeds original expectations for European reimbursement, initially projected at only €40K per patient.

Pricing And Reimbursement ChallengesSanthera continues to engage in pricing negotiations and reimbursement decisions across multiple key European territories, indicating steady progress and market uptake.

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

0.06%

Mutual Funds

― Other Institutional Investors

99.45% Public Companies and

Individual Investors

Detailed Ownership Overview >

SANN FAQ

What was Santhera Pharmaceuticals Holding Ag’s price range in the past 12 months?

Santhera Pharmaceuticals Holding Ag lowest stock price was CHF7.21 and its highest was CHF17.76 in the past 12 months.

What is Santhera Pharmaceuticals Holding Ag’s market cap?

Santhera Pharmaceuticals Holding Ag’s market cap is CHF118.01M.

When is Santhera Pharmaceuticals Holding Ag’s upcoming earnings report date?

Santhera Pharmaceuticals Holding Ag’s upcoming earnings report date is Sep 10, 2025 which is in 85 days.

How were Santhera Pharmaceuticals Holding Ag’s earnings last quarter?

Santhera Pharmaceuticals Holding Ag released its earnings results on Apr 29, 2025. The company reported -CHF0.74 earnings per share for the quarter, the consensus estimate of -CHF0.74 by CHF0.

Is Santhera Pharmaceuticals Holding Ag overvalued?

According to Wall Street analysts Santhera Pharmaceuticals Holding Ag’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Santhera Pharmaceuticals Holding Ag pay dividends?

Santhera Pharmaceuticals Holding Ag does not currently pay dividends.

What is Santhera Pharmaceuticals Holding Ag’s EPS estimate?

Santhera Pharmaceuticals Holding Ag’s EPS estimate is -0.6.

How many shares outstanding does Santhera Pharmaceuticals Holding Ag have?

Santhera Pharmaceuticals Holding Ag has 13,524,123 shares outstanding.

What happened to Santhera Pharmaceuticals Holding Ag’s price movement after its last earnings report?

Santhera Pharmaceuticals Holding Ag reported an EPS of -CHF0.74 in its last earnings report, expectations of -CHF0.74. Following the earnings report the stock price went down -3.141%.

Which hedge fund is a major shareholder of Santhera Pharmaceuticals Holding Ag?

Currently, no hedge funds are holding shares in CH:SANN

Company Description

Santhera Pharmaceuticals Holding Ag

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as treatments for Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises lonodelestat (POL6014) to treat cystic fibrosis and other neutrophilic pulmonary diseases, as well as omigapil that treats congenital muscular dystrophies. The company also out-licenses outside North America and France rights to its approved product, Raxone (idebenone), for the treatment of Leber's hereditary optic neuropathy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland.

SANN Company Deck

SANN Earnings Call

Q4 2025

0:00 / 0:00

SANN Stock 12 Month Forecast

Average Price Target

CHF29.98

▲(145.78%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"CHF6","19":"CHF19","32":"CHF32","12.5":"CHF12.5","25.5":"CHF25.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":29.9845815474,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF29.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29.9845815474,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF29.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29.9845815474,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF29.98</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,12.5,19,25.5,32],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2023","6":"Jan<br/>2024","9":"Dec<br/>2024","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.5,15.691121657492308,16.882243314984617,18.073364972476924,19.26448662996923,20.455608287461537,21.646729944953847,22.837851602446154,24.02897325993846,25.22009491743077,26.411216574923078,27.602338232415384,28.793459889907695,{"y":29.9845815474,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.5,15.691121657492308,16.882243314984617,18.073364972476924,19.26448662996923,20.455608287461537,21.646729944953847,22.837851602446154,24.02897325993846,25.22009491743077,26.411216574923078,27.602338232415384,28.793459889907695,{"y":29.9845815474,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.5,15.691121657492308,16.882243314984617,18.073364972476924,19.26448662996923,20.455608287461537,21.646729944953847,22.837851602446154,24.02897325993846,25.22009491743077,26.411216574923078,27.602338232415384,28.793459889907695,{"y":29.9845815474,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":31.9,"date":1622505600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":14.2,"date":1648771200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.42,"date":1656633600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.25,"date":1688169600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.94,"date":1696118400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.59,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.81,"date":1704067200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.5,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.35,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.19,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.82,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.12,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.5,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >